Northwestern scientists have determined how two protein mutations responsible for the impaired motor function in Parkinson’s disease independently disrupt neuron activity.
Combining the current standard-of-care chemotherapy drug with a genetic inhibitor may improve treatment for pancreatic ductal adenocarcinoma, according to a recent study published in PNAS.
Feinberg investigators are breaking down the mechanisms of aging and designing solutions to extend healthy living.
During a recent webinar, Elizabeth McNally, MD, PhD, the Elizabeth J. Ward Professor of Genetic Medicine and director of the Center for Genetic Medicine, discussed findings from the ongoing Screening for Coronavirus Antibodies in Neighborhoods (SCAN) study and what genetics can reveal about COVID-19.
A viral protein of the Epstein-Barr virus previously thought to mimic immune cell receptor signaling actually rewires intracellular signaling in infected cells, promoting viral cell survival and proliferation.
Astrocytes may play a protective role in Parkinson’s disease, slowing alpha-synuclein accumulation in neurons, according to a study published in The Journal of Neuroscience.
The three-year grant from the Centers for Disease Control and Prevention will fund the first-ever study looking at how sibling relationships influence firearm involvement.
A new three-dimensional imaging technique invented by Northwestern scientists greatly improves the visibility of brain tumors in magnetic resonance imaging scans.
Targeting the proteins CD47 and HER2 may eliminate radioresistant breast cancer cells and enable more effective radiotherapy treatments for patients, according to a new study.
The impact of COVID-19 on cancer patients has been a stark reality for many cancer centers around the world. For the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a combination of time and dedication to patient care and research has resulted in the development of robust COVID-19 testing protocols to ensure the safety…
Notifications